Uroplasty Inc (UPI)

1.22
0.03 2.40
Prev Close 1.25
Open 1.26
Day Low/High 1.18 / 1.29
52 Wk Low/High 1.05 / 4.05
Volume 236.64K
Avg Volume 207.20K
Exchange
Shares Outstanding 22.15M
Market Cap 27.01M
EPS -0.25
Div & Yield N.A. (N.A)

Latest News

UPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Uroplasty, Inc. Regarding The Fairness Of The Sale Of The Company To Vision-Sciences, Inc. - UPI

UPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Uroplasty, Inc. Regarding The Fairness Of The Sale Of The Company To Vision-Sciences, Inc. - UPI

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Uroplasty, Inc.

UROPLASTY, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Vision-Sciences, Inc.

UROPLASTY, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Vision-Sciences, Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Uroplasty, Inc.

Why Uroplasty (UPI) Hit A Two-Year High Today

Why Uroplasty (UPI) Hit A Two-Year High Today

Uroplasty (UPI) hits a two-year high of $5.40 on Friday after the company reported revenue of $6.4 million, up 14% from the same period one year earlier. Domestic sales of the company's Urgent PC Neuromodulation System grew 19% to $3.2 million, up from $2.7 million in the same quarter one year earlier. Domestic sales of Macroplastique grew 11% to $1.5 million, while net sales outside of the U.S. grew 11% to $1.6 million.

Investor Alert: Federman & Sherwood Reminds Investors With Large Losses In Uroplasty, Inc. Of Upcoming Deadline In Securities Class Action Lawsuit

Investor Alert: Federman & Sherwood Reminds Investors With Large Losses In Uroplasty, Inc. Of Upcoming Deadline In Securities Class Action Lawsuit

Federman & Sherwood announces that on July 1, 2013, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Uroplasty, Inc.

Law Offices Of Todd M. Garber Announces Investigation Of Uroplasty, Inc.

Law Offices Of Todd M. Garber Announces Investigation Of Uroplasty, Inc.

The Law Offices of Todd M. Garber announces that it is investigating potential claims against Uroplasty, Inc.

Law Firm Finkelstein Thompson LLP Announces Investigation Of UPI Inc.

Law Firm Finkelstein Thompson LLP Announces Investigation Of UPI Inc.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Uroplasty, Inc.

Uroplasty Inc. Stock Downgraded (UPI)

Uroplasty Inc. Stock Downgraded (UPI)

Uroplasty (Nasdaq:UPI) has been downgraded by TheStreet Ratings from from a hold to sell.

Uroplasty Stock Gaps Down On Today's Open (UPI)

Shares of Uroplasty (Nasdaq:UPI) were gapping down Friday morning with an open price 11.3% lower than Thursday's closing price. The stock closed at $7.43 yesterday and opened today's trading at $6.59.

Uroplasty Inc. Stock Downgraded (UPI)

Uroplasty (Nasdaq:UPI) has been downgraded by TheStreet Ratings from from a hold to sell.

10 Health-Care Stocks Outperforming the Index

These health-care stocks delivered attractive returns in the past one month, outperforming the index.

Stock Offerings: CenterState Banks

CenterState Banks prices an offering of common stock at discount to the previous session's closing price.

Westell Tech, Somaxon: Volume Movers

Several stocks trading near $5, including Westell Technologies, were poised to move on above-average volume Thursday.

A Rally Next Week Remains Possible

The numbers suggest an oversold rally is likely to begin sometime over the next few trading days.